Mortality News and Research

RSS

R21/Matrix-M booster maintains high efficacy against first and multiple episodes of clinical malaria

The phase 1/2b clinical trial on R21/Matrix-M malaria vaccine has recently reported the safety and efficacy of booster vaccination at 12 months.

15 Sep 2022

Concern over two cases of monkeypox-related neurological complications in the U.S.

A new study published in the CDC's Morbidity and Mortality Weekly Report analyzed two people with encephalomyelitis associated with monkeypox disease in Colorado and DC during the current outbreak.

15 Sep 2022

Study highlights the efficacy of MVA-BN booster vaccination in inducing durable B cell memory responses against monkeypox

In a new study, researchers assessed the immunogenicity, safety, and booster-efficacy of the Modified Vaccinia virus Ankara-Bavarian Nordic (MVA-BN) vaccine currently being used for immunization against monkeypox.

14 Sep 2022

California and New York aim to curb diet pill sales to minors

California and New York are on the cusp of going further than the FDA in restricting the sale of non-prescription diet pills to minors as pediatricians and public health advocates try to protect kids from extreme weight-loss gimmicks online.

14 Sep 2022

Study explores the impact of genetic risk variants on overall disease burden and healthy life years

In a new study, researchers explored the genetic risk factors associated with various diseases to understand their impact on healthy life years.

14 Sep 2022

Risk of dementia reduced 50% by walking 9,800 steps a day

In a recent study published in JAMA Neurology, researchers assessed the association between the number and intensity of steps taken per day and dementia incidence among adults residing in the United Kingdom (UK).

14 Sep 2022

Every step counts to lower cancer and cardiovascular disease risk

In a recent study published in JAMA Internal Medicine, researchers in Australia, Denmark, and the United States pursued evidence of an association between daily walking and its intensity with the risk of cancer and cardiovascular diseases (CVDs) in a cohort of 78,500 individuals aged 40 to 79 years in the United Kingdom (UK).

13 Sep 2022

Study finds spike in the "Years of Life Lost" among adolescents during COVID-19 pandemic

The first year of the COVID-19 pandemic saw a 113% increase in the "Years of Life Lost" among adolescents and young people in the United States due to unintentional drug overdose, according to researchers at The Ohio State University Wexner Medical Center and College of Medicine.

13 Sep 2022

Efficacy and safety of monoclonal antibodies against SARS-CoV-2 during pregnancy

In an article published in the journal Expert Opinion on Drug Safety, scientists have described the safety and efficacy profiles of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal antibodies in pregnant women with coronavirus disease 2019 (COVID-19).

13 Sep 2022

COVID found to be the leading cause of death for people with intellectual and developmental disabilities

Authors of a new peer-reviewed paper have discovered that COVID was the leading cause of death for people with intellectual and developmental disabilities (IDD) in 2020.

13 Sep 2022

Experimental drug prolongs survival, improves muscle function in mice severe Duchenne muscular dystrophy

Researchers at Johns Hopkins Medicine report that an experimental drug first developed to treat kidney disease prolongs survival and improves muscle function in mice genetically engineered to develop a severe form of Duchenne muscular dystrophy (DMD).

13 Sep 2022

What is the effectiveness of tecovirimat for treatment of monkeypox?

Researchers assessed the effectiveness of tecovirimat in monkeypox treatment in a new study.

13 Sep 2022

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

Researchers identified type 3 vaccine-derived poliovirus (VDPV) in an infant.

13 Sep 2022

Study investigates the prevalence of adrenal tumors in an unselected screening population

A cross-sectional study of more than 25,000 adults has found that with increased screening, the prevalence of adrenal tumors in an unselected community population was 1.4%. The prevalence increased with age, from 0.2% in adults aged 18 to 25 up to 3.2% in adults older than 65 years of age. However, approximately 70% of identified tumors were nonfunctioning, meaning they did not make extra hormones, regardless of the participant's age. The findings are published in Annals of Internal Medicine.

13 Sep 2022

The maternal and perinatal outcomes of pregnancies complicated by monkeypox infection

A new study reviews the available evidence on the impact of monkeypox infection during pregnancy.

13 Sep 2022

How effective is vitamin D supplementation in COVID-19?

The current paper addresses the considerable evidence now supporting the efficacy of vitamin D in COVID-19, as well as its safety.

13 Sep 2022

World Sepsis Day 2022: Raising Sepsis Awareness with Sepsis Research FEAT

For World Sepsis Day 2022, News Medical speaks to Colin Graham, COO of Sepsis Research FEAT, about the importance of sepsis awareness, research, and potentially life-changing breakthroughs.

13 Sep 2022

False positive monkeypox tests in low-risk patients with no exposures

Researchers reported three monkeypox diagnoses presenting atypical rashes.

13 Sep 2022

Study investigates BMI, race, and lung cancer diagnosis relationships

Lung cancer is the leading cause of cancer death in the US, making up 25% of cancer deaths. With obesity rates simultaneously rising, researchers have investigated the connections between cancer risk and body mass index (BMI). Unlike most other cancer types, where higher BMI is associated with increased risk of cancer, research has established that paradoxically people with higher BMI have lower rates of lung cancer diagnosis.

13 Sep 2022

Saline nasal irrigation after COVID-19 diagnosis reduces hospitalization

Starting twice daily flushing of the mucus-lined nasal cavity with a mild saline solution soon after testing positive for COVID-19 can significantly reduce hospitalization and death, investigators report.

13 Sep 2022

Mortality News and Research

R21/Matrix-M booster maintains high efficacy against first and multiple episodes of clinical malaria

Concern over two cases of monkeypox-related neurological complications in the U.S.

Study highlights the efficacy of MVA-BN booster vaccination in inducing durable B cell memory responses against monkeypox

California and New York aim to curb diet pill sales to minors

Study explores the impact of genetic risk variants on overall disease burden and healthy life years

Risk of dementia reduced 50% by walking 9,800 steps a day

Every step counts to lower cancer and cardiovascular disease risk

Study finds spike in the "Years of Life Lost" among adolescents during COVID-19 pandemic

Efficacy and safety of monoclonal antibodies against SARS-CoV-2 during pregnancy

COVID found to be the leading cause of death for people with intellectual and developmental disabilities

Experimental drug prolongs survival, improves muscle function in mice severe Duchenne muscular dystrophy

What is the effectiveness of tecovirimat for treatment of monkeypox?

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

Study investigates the prevalence of adrenal tumors in an unselected screening population

The maternal and perinatal outcomes of pregnancies complicated by monkeypox infection

How effective is vitamin D supplementation in COVID-19?

World Sepsis Day 2022: Raising Sepsis Awareness with Sepsis Research FEAT

False positive monkeypox tests in low-risk patients with no exposures

Study investigates BMI, race, and lung cancer diagnosis relationships

Saline nasal irrigation after COVID-19 diagnosis reduces hospitalization

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News